Aminosalicylic Acid Completed Phase 2 Trials for Malignant Neoplasm of Stomach Treatment

CompletedTreatment2 IdentifierTitleDrugs
NCT02233712Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.
NCT02518529Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients
NCT02521649Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer